IDORSIA LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.208 CHF | -2.13% |
|
-5.88% | +4.45% |
| May. 21 | Idorsia Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| May. 21 | Swiss Stocks Flash Red Amid Economic Data Focus in Europe | MT |
Chart calendar Idorsia Ltd
ec444fa33.SKWkfNN7N6t4ZiVRjN87xw010zbkEZSVqvCMAsrvErs.J53IP4UhfuQqE3Bp4pp-mHxnhkOMQq39_4nBYYy2eIwYwZ0Q4QIE_TZWZA~3dd12241536f50f89761aaffe4cd7719
Upcoming events on Idorsia Ltd
Past events on Idorsia Ltd
| 2024-05-21 08:00 am | Q1 2024 Earnings Call - Q4 2023 |
| 2024-05-21 01:00 am | Q1 2024 Earnings Release - Q4 2023 |
| 2024-05-05 | Shareholders Meeting |
| 2024-04-10 | Annual General Meeting |
| 2024-03-20 10:00 am | TRYVIO FDA Approval Call |
| 2024-01-10 01:30 pm | JPMorgan Healthcare Conference |
| 2023-11-13 | Credit Suisse Equity Forum |
| 2023-10-24 09:00 am | Q3 2023 Earnings Call |
| 2023-10-24 01:00 am | Q3 2023 Earnings Release |
| 2023-09-17 | Baader Investment Conference |
| 2023-09-12 | Bank of America Global Healthcare Conference |
| 2023-09-10 | Morgan Stanley Global Healthcare Conference |
| 2023-09-05 | Citi BioPharma Conference |
| 2023-07-25 09:00 am | Q2 2023 Earnings Call |
| 2023-07-25 01:00 am | Q2 2023 Earnings Release |
| 2023-06-28 | Stifel European Healthcare Summit |
| 2023-06-21 | J.P. Morgan European Healthcare Conference |
| 2023-06-19 | Citi European Healthcare Conference |
| 2023-06-11 | Goldman Sachs Global Healthcare Conference |
| 2023-06-06 | Jefferies Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 24,0 36,2 -33.75% | 72,0 73,8 -2.39% | 35,0 39,5 -11.29% | 97,0 79,5 21.99% | 152 138 9.85% | 135 |
|
EBITDA Million CHF | Released Forecast Spread | -462 -472 2.02% | -391 -388 -0.86% | -595 -562 -5.81% | -737 -792 6.87% | -482 -401 -20.26% | -371 |
|
EBIT Million CHF | Released Forecast Spread | -482 -486 0.73% | -411 -412 0.21% | -613 -580 -5.65% | -757 -836 9.48% | -501 -307 -62.97% | -389 |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -485 -482 -0.56% | -449 -442 -1.54% | -635 -609 -4.19% | -820 -868 5.49% | -294 -422 30.35% | -407 |
|
Net income Million CHF | Released Forecast Spread | -494 -486 -1.56% | -445 -443 -0.5% | -635 -606 -4.78% | -828 -869 4.67% | -298 -350 14.92% | -407 |
|
EPS CHF | Released Forecast Spread | -3,76 -3,60 -4.44% | -3,11 -3,02 -3.07% | -3,77 -3,65 -3.32% | -4,67 -4,78 2.31% | -1,67 -1,72 2.9% | -1,49 |
| Announcement Date | 06/02/20 | 04/02/21 | 08/02/22 | 07/02/23 | 21/05/24 | - |
Quarterly results
| Fiscal Period | December | 2021 S1 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 13,0 11,5 13.04% | 5,00 9,64 -48.12% | 17,0 15,0 13.36% | 21,0 27,8 -24.41% | 54,0 37,5 44.03% | 21,0 31,5 -33.28% | 30,0 34,0 -11.78% | 80,0 18,4 335.16% | 22,0 21,3 3.3% | 10,1 15,4 -34.81% | 112 | 13,4 | 21,1 | 52,5 |
|
EBITDA Million CHF | Released Forecast Spread | -188 -190 1.31% | -207 -202 -2.4% | -189 -191 0.96% | -174 -231 24.38% | -193 -208 7.33% | -173 -183 5.58% | -37,0 | |||||||
|
EBIT Million CHF | Released Forecast Spread | -234 -268 12.52% | -193 -198 2.41% | -212 -214 0.96% | -193 -205 5.91% | -180 -239 24.7% | -198 -198 0% | -177 -192 7.77% | 231 -179 228.98% | -115 -150 23.2% | 30,9 30,9 0% | -16,5 | -121 | -124 | -80,4 |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -196 -221 11.23% | -222 -226 1.58% | -216 -219 1.37% | -190 -245 22.42% | -212 -217 2.46% | -192 -198 3.23% | 225 -184 221.99% | -116 -179 35.3% | ||||||
|
Net income Million CHF | Released Forecast Spread | -223 -262 14.72% | -198 -212 6.41% | -222 -219 -1.59% | -216 -210 -3.06% | -193 -261 26.03% | -212 -216 1.64% | -193 -204 5.18% | 224 -184 221.45% | -117 -179 34.74% | |||||
|
EPS CHF | Released Forecast Spread | -1,34 -1,57 14.65% | -1,12 -1,15 2.64% | -1,25 -1,25 -0.09% | -1,22 -1,21 -0.87% | -1,09 -1,37 20.7% | -1,19 -1,15 -3.52% | -1,08 -0,98 -10.35% | 0,96 -1,05 191.14% | -0,65 -0,81 19.75% | 0,13 -0,19 168.42% | -0,10 | -0,41 | -0,30 | -0,20 |
| Announcement Date | 27/07/21 | 26/04/22 | 26/07/22 | 25/10/22 | 07/02/23 | 25/04/23 | 25/07/23 | 24/10/23 | 21/05/24 | 21/05/24 | - | - | - | - |
More events
Past sector events for Idorsia Ltd
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-15 04:01 pm | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IDIA Stock
- Calendar Idorsia Ltd
